PRKACB anticorps
-
- Antigène Voir toutes PRKACB Anticorps
- PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))
-
Reactivité
- Humain, Rat, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PRKACB est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Attributs du produit
- Expected molecular weight of target: 351 kDa
- Purification
- Affinity purification
- Immunogène
- Recombinant protein of human PRKACB
- Isotype
- IgG
- Top Product
- Discover our top product PRKACB Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200, IF 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C.
-
- Antigène
- PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))
- Autre désignation
- PRKACB (PRKACB Produits)
- Synonymes
- anticorps PKACB, anticorps XPKAbeta, anticorps kin-1, anticorps pkacb, anticorps prkacba, anticorps PRKACB, anticorps prkacb, anticorps wu:fz54b03, anticorps zgc:110804, anticorps Pkacb, anticorps protein kinase cAMP-activated catalytic subunit beta, anticorps protein kinase cAMP-activated catalytic subunit beta S homeolog, anticorps protein kinase, cAMP-dependent, catalytic, beta, anticorps protein kinase, cAMP-dependent, catalytic, beta b, anticorps protein kinase, cAMP dependent, catalytic, beta, anticorps PRKACB, anticorps prkacb.S, anticorps prkacb, anticorps Prkacb, anticorps prkacbb
- ID gène
- 5567
- UniProt
- P22694
- Pathways
- AMPK Signaling, Signalisation Hedgehog, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Lipid Metabolism
-